Tango Therapeutics TNGX
NASDAQ TNGX
$23.24 -1.21 (-4.95%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Return on Sales [ROS] (2020 - 2026)

Updated

Tango Therapeutics (TNGX) posted Return on Sales [ROS] of -253.38% for Q2 2026, up 1034.49 percentage points from -1287.87% a year earlier but down 47.16 percentage points from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

For FY2025, Tango Therapeutics' Return on Sales [ROS] came in at -178.39%, up 167.69 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +503.42 percentage points (FY2020 to FY2025).
  • In prior years, Tango Therapeutics' Return on Sales [ROS] was -346.09% in FY2024 (-33.51 pp), -312.57% in FY2023 (+134.21 pp), -446.79% in FY2022 (-289.69 pp) and -157.09% in FY2021 (+524.73 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -1287.87% in Q2 2025 to a high of 26.15% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Sales [ROS] has increased in each of the last four quarters, with an average year-over-year change of +134.16 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2026, with a gain of 1034.49 percentage points; the weakest was Q2 2025, with a drop of 1139.18 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -206.22% (Q1 2026), -178.39% (Q4 2025) and 26.15% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Tango Therapeutics 3.91 Bn 2.02 Bn - -253.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -253.38%
Mar 31, 2026 -206.22%
Dec 31, 2025 -178.39%
Sep 30, 2025 26.15%
Jun 30, 2025 -1,287.87%
Mar 31, 2025 -788.76%
Dec 31, 2024 -993.68%
Sep 30, 2024 -283.26%
Jun 30, 2024 -148.69%
Mar 31, 2024 -652.99%
Dec 31, 2023 -644.69%
Sep 30, 2023 -238.78%
Jun 30, 2023 -159.25%
Mar 31, 2023 -525.25%
Dec 31, 2022 -476.79%
Sep 30, 2022 -432.41%
Jun 30, 2022 -436.70%
Mar 31, 2022 -440.76%
Dec 31, 2021 -384.60%
Sep 30, 2021 -288.33%
API Access

Tango Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TNGX&period=max&api_key=YOUR_API_KEY